Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Net Cash Flow: 2016-2025

Historic Net Cash Flow for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $32.8 million.

  • Collegium Pharmaceutical's Net Cash Flow rose 130.07% to $32.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.0 million, marking a year-over-year increase of 154.47%. This contributed to the annual value of -$143.4 million for FY2024, which is 324.88% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Net Cash Flow stood at $32.8 million for Q3 2025, which was up 54.83% from $21.2 million recorded in Q2 2025.
  • Collegium Pharmaceutical's Net Cash Flow's 5-year high stood at $95.8 million during Q1 2023, with a 5-year trough of -$108.9 million in Q3 2024.
  • In the last 3 years, Collegium Pharmaceutical's Net Cash Flow had a median value of $12.8 million in 2023 and averaged -$475,909.
  • Over the last 5 years, Collegium Pharmaceutical's Net Cash Flow had its largest YoY gain of 680.51% in 2022, and its largest YoY loss of 1,019.16% in 2022.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Net Cash Flow stood at -$6.8 million in 2021, then surged by 680.51% to $39.6 million in 2022, then slumped by 149.50% to -$19.6 million in 2023, then surged by 261.37% to $31.6 million in 2024, then spiked by 130.07% to $32.8 million in 2025.
  • Its Net Cash Flow stands at $32.8 million for Q3 2025, versus $21.2 million for Q2 2025 and $20.5 million for Q1 2025.